This prediction is currently active. The BUY prediction by investresearch for Carl Zeiss Meditec AG is nearly unchanged. This prediction currently runs until 28.12.25. The prediction end date can be ...
The projected fair value for Carl Zeiss Meditec ... % higher than Carl Zeiss Meditec's analyst price target of €61.30 Does the December share price for Carl Zeiss Meditec AG (ETR:AFX) reflect ...
There's been a notable change in appetite for Carl Zeiss Meditec AG (ETR ... This implies to us that there is a fairly broad range of possible scenarios for the underlying business.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
The projected fair value for Carl Zeiss Meditec ... Cash Flow to Equity Carl Zeiss Meditec is estimated to be 41% undervalued based on current share price of €45.52 Our fair value estimate is 27% ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...